Dr. Richard Deckelbaum, New York NY - MD (Doctor of Medicine)
Specialties:
Pediatrics
Address:
3959 Broadway SUITE 7TH, New York 10032 (212) 305-5903 (Phone), (212) 544-1974 (Fax) W 1562 630 W 168Th St SUITE 15, New York 10032 (212) 305-9235 (Phone), (212) 305-5958 (Fax)
Certifications:
Pediatrics, 1974
Awards:
Healthgrades Honor Roll
Languages:
English, French
Education:
Medical School McGill University / Faculty of Medicine
Richard J Deckelbaum, New York NY
Specialties:
Pediatrics, Pediatric Gastroenterology
Work:
Columbia University 3959 Broadway, New York, NY 10032Columbia University 630 W 168Th St, New York, NY 10032
Education:
McGill University Faculty Of Medicine (1967)
Richard Deckelbaum, New York NY
Specialties:
Pediatrician
Address:
3959 Broadway, New York, NY 10032 630 W 168Th St, New York, NY 10032
Omega-3 Diglyceride Emulsions
US Patent:
2013017, Jul 11, 2013
Filed:
Mar 4, 2013
Appl. No.:
13/783779
Inventors:
Richard J. DECKELBAUM - Hastings on Hudson NY, US Yvon CARPENTIER - Brussels, BE
Assignee:
The Trustees of Columbia University in The City of New York - New York NY
International Classification:
A61K 31/231
US Classification:
514547
Abstract:
The present invention relates to omega-3 diglyceride emulsions characterized in that the lipid phase comprises at least about 40 wt.-% of diglycerides. Preferably about 70 wt.-% of the acyl-groups of said diglycerides, are eicoapentaenoic acid (EPA) groups and/or docasahexaenoic (DHA) groups. The invention further relates to methods of treatment using the omega-3 diglyceride emulsions.
Omega-3 Diglyceride Emulsions
US Patent:
8633253, Jan 21, 2014
Filed:
Jul 29, 2013
Appl. No.:
13/953718
Inventors:
Richard J. Deckelbaum - Hastings on Hudson NY, US Yvon Carpentier - Brussels, BE
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
B01F 3/00
US Classification:
516 9
Abstract:
The present invention relates to omega-3 diglyceride emulsions characterized in that the lipid phase comprises at least about 40 wt. -% of diglycerides. Preferably about 70 wt. -% of the acyl-groups of said diglycerides, are eicoapentaenoic acid (EPA) groups and/or docasahexaenoic (DHA) groups. The invention further relates to methods of treatment using the omega-3 diglyceride emulsions.